Couto SS, Griffey SM, Duarte PC. Feline vaccine-associated fibrosarcoma: morphologic distinctions. Vet Pathol 2002;39:33–41.
Hartmann K. Clinical aspects of feline retroviruses: a review. Viruses 2012;4:2684–2710.
Hartmann K, Day MJ, Thiry E, et al. Feline injection-site sarcoma: ABCD guidelines on prevention and management. J Feline Med Surg 2015;17:606–613.
Vaccine-Associated Feline Sarcoma Task Force. The current understanding and management of vaccine-associated sarcomas in cats. J Am Vet Med Assoc 2005;226:1821–1842.
Doddy FD, Glickman LT, Glickman NW, et al. Feline fibrosarcomas at vaccination sites and non-vaccination sites. J Comp Pathol 1996;114:165–174.
Holtermann N, Kiupel M, Hirschberger J. The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects. Vet Comp Oncol 2017;15:632–640.
Manfredi S, Volta A, Fabbi M, et al. What Is Your Diagnosis? Myxosarcoma in a cat. J Am Vet Med Assoc 2015;247:597–599.
Attipa C, Beck S, Lipscomb V, et al. Aldosterone-producing adrenocortical carcinoma with myxoid differentiation in a cat. Vet Clin Pathol 2018;47:660–664.
Headley SA, Faria Dos Reis AC, Bracarense AP. Cutaneous myxosarcoma with pulmonary metastases in a dog. J Comp Pathol 2011;145:31–34.
Willems SM, Wiweger M, van Roggen JFG, et al. Running GAGs: myxoid matrix in tumor pathology revisited: what’s in it for the pathologist? Virchows Arch 2010;456:181–192.
Ehrhart N. Soft-tissue sarcomas in dogs: a review. J Am Anim Hosp Assoc 2005;41:241–246.
Saba CF. Vaccine-associated feline sarcoma: current perspectives. Vet Med (Auckl) 2017;8:13–20.
Advertisement